baber/WOPTO huggingface dataset:
Patent YU-205883-A (YU)
Title: Apparatus for brightness measuring
Inventor: CABI AKMAN R
IPC: G01N21/55
Filed: 1983-10-12
Abstract: A sample to be measured, a black reference and at least one reference having a color similar to that of the sample are exposed successively and cyclicly to the same incident light beam, the light beams which are reflected successively by the sample and the references are detected photoelectrically, the ratio of the intensities of the light beams reflected by a sample and one reference color on the one hand and by the black reference and a reference color on the other hand is established electronically, the second ratio is subtracted electronically from the first and a difference which is directly proportional to the brilliance of the color of the sample is automatically obtained during each exposure or measurement cycle at a determined measurement frequency (FIG. 1).
Patent YU-305381-A (YU)
Title: Linked connection of plates with hollow chambers for covering swimming pools
Inventor: ARTUR FISCHER
IPC: E04H4/10
Filed: 1981-12-22
Abstract: A hinge joint for joining hollow panels utilized for covering swimming pools includes two leaf-like connecting parts with overlapped portions each having an axial bore to receive a hinge pin. Each connecting part has a supporting bar hooked into a bore provided in the outside face of the cover panel and extended into the cavity formed in the hollow panel.
Patent YU-11502-A (YU)
Title: Rhodium/inorganic iodide catalyst system for methanol carbonylation process with improved impurity profile
Inventor: SCATES MARK O
IPC: C07B61/00
Filed: 2000-08-07
Abstract: The method of the present invention provides an improvement upon prior art methanol carbonylation methods which substantially reduces the production of carbonyl impurities. The production of carbonyl impurities, particularly acetaldehyde, crotonaldehyde, and 2- ethyl crotonaldehyde, in methanol carbonylation reactions has been found to decrease by maintaining a partial pressure of hydrogen between about 0.1 and 4 psia at reaction total pressure of from about 15 to about 40 atmospheres total reaction pressure.
Patent RS-89904-A (RS)
Title: Medicaments containing steroids and a novel anticholinesterase drug
Inventor: BANHOLZER ROLF
IPC: A61K47/10
Filed: 2003-04-09
Abstract: The invention relates to novel medicament compositions based on long-acting steroids and salts of a novel anticholinesterase drug, to methods for the production of these compositions and their use in treating respiratory tract diseases.
Patent AP-375-A (AP)
Title: Selective mining method and apparatus.
Inventor: BUYENS Marc Octave Rene Ghilslain Buyer
IPC: E21C41/16
Filed: 1992-02-28
Granted: 1995-01-11
Abstract: The method is
Patent AP-1186-A (AP)
Title: Thiol derivatives with metallopeptidase inhibitory activity.
Inventor: PELLACINI FRANCO
IPC: C07D307/54
Filed: 1996-12-17
Granted: 2003-07-07
Abstract: Compounds of formula (i), wherein r, r1, r2, and r3 have the meanings reported in the description, processes for their preparation and pharmaceutical compositions which contain them as active ingrdients are described. The compounds of formula (i)are windowed with ace-inhibitory and nep-inhibitory activity and are useful in the treatment of cardiovascular diseases.
Patent AU-1039997-A (AU)
Title: Carbapenem-3-carboxylic acid ester derivatives
Inventor: ABE TAKAO
IPC: C07D477/20
Filed: 1996-12-04
Abstract: PCT No. PCT/JP96/03540 Sec. 371 Date Jul. 17, 1997 Sec. 102(e) Date Jul. 17, 1997 PCT Filed Dec. 4, 1996 PCT Pub. No. WO97/21712 PCT Pub. Date Jun. 19, 1997Disclosed are carbapenem-3-carboxylic acid ester derivatives of formula (I), wherein R1 is a hydrogen atom or a lower alkyl group, R2 is an alkyl group which may be substituted by a cycloalkyl group having about 4 to 7 carbon atoms and which may be substituted by a lower alkyl group, or is a cycloalkyl group having 4 to 7 carbon atoms which may be substituted by a lower alkyl group and n is 0 or 1. The compounds are highly absorbable through the digestive tract and are rapidly converted in the body to the active compound, which shows strong antibacterial activity.    <IMAGE>  (I)
Patent AU-1074092-A (AU)
Title: Ester of an oxidized polyethylene wax and its use as lubricant in plastic molding compositions
Inventor: HOHNER GERD
IPC: C08F8/14
Filed: 1992-02-06
Abstract: An ester made from an oxidised polyethylene wax and a monofunctional C1- to C8-alkanol has, as a lubricant, a very strong release action in thermoplastic moulding compositions, in particular based on vinyl chloride polymers. In addition, it does not reduce the transparency, in particular in calendered films or sheeting.
Patent AU-1074102-A (AU)
Title: Liquid dosing devices
Inventor: SLADE BRIAN
IPC: A47K3/00
Filed: 2001-10-30
Abstract: A device for dosing a liquid product into a flow of liquid, the device comprising a dosing chamber (6) for the liquid product (P), said chamber having a porous wall (26) through which the liquid product (P) is transported when the porous wall (26) is within the flow of liquid (F) but which retains the liquid product (P) within the dosing chamber (6) when the liquid flow (F) is removed. <IMAGE>
Patent AU-1132892-A (AU)
Title: Process for the genetic manipulation of myxobacteria
Inventor: JAOUA SAMIR
IPC: C12R1/01
Filed: 1992-02-28
Abstract: The present invention relates to a process for the genetic manipulation of myxobacteria, preferably of myxobacteria from the Sorangium/Polyangium group, which makes possible for the first time specific application of recombinant DNA techniques to this group of organisms. The industrial implementation of this process is primarily based on the preparation of recombinant DNA molecules which, by reason of their specific construction, are able to integrate genes or DNA sequences which, where appropriate, code for novel and desirable properties, with the aid of homologous recombination at sites, which are accurately defined by reason of the homologies present, within the bacterial genome, and on the insertion thereof into the myxobacterial cell.
Patent AU-1239901-A (AU)
Title: Compositions and methods utilizing dna polymerases
Inventor: SORGE JOSEPH A
IPC: C12Q1/68
Filed: 2000-10-27
Abstract: The invention features a novel isolated Family B DNA polymerase, a Thermococcus polymerase JDF-3, and mutant recombinant forms thereof. Mutant polymerases of the invention are deficient in 3' to 5' exonuclease activity and/or exhibit reduced discrimination against non-conventional nucleotides relative to the wild-type form of the polymerase.
Patent AU-1312688-A (AU)
Title: A device for collecting and temporarily storing urine
IPC: A61F5/451
Filed: 1988-03-15
Abstract: Device for collecting and temporarily storing urine, and is intended particularly, but not exclusively, for bed-ridden persons or patients and is characterized by the combination of   a) a urine tube (1) provided with a first and a second aperture, the first aperture being intended to form a urine inlet end and being so shaped as to enable it to be used by both men and women, b) a urine bag (8) having an inlet end and an openable and closable outlet end, c) a valve means (6) which includes a valve body (7) which has a substantially U-shape in longitudinal section and one end of which is intended to co-act in a liquid-tight manner with said second aperture, and the other end of which valve body is intended to co-act with the inlet end of the urine bag, and wherein at least the valve means (6) and the urine bag (8) form an undivided and liquid-tight urine collecting device, or preferably wherein the urine tube (1), valve means (6) and urine bag (8) together form an undividable or inseparable assembly.
Patent AU-1382292-A (AU)
Title: Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
Inventor: CARTER GUY THOMAS
IPC: A23K20/195
Filed: 1992-03-26
Abstract: This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta  or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha  are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference);  Molecular weight: 1225 (FABMS);  Apparent molecular formula: C65H95NO21;  Specific rotation: [ alpha ]26_D = O (C 0.385, methanol);   LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference);  Molecular weight: 1225 (FABMS);  Apparent molecular formula:  C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol);
Patent AU-1521392-A (AU)
Title: Compounds
IPC: A61K31/50
Filed: 1992-04-28
Abstract: Compsn. for treating neurological disorders contains, apart from a diluent or carrier, a pyridazino-quinoline cpd. of formula (I) or its pharmaceutically acceptable salt. R3 = H, NH2, NHNH2, OH or SH; A = (Ia) (any one C atom not involved in the ring junction can be replaced by N); R4-R7 = H, halo, 1-4C alkyl (opt. contg. double or triple bond), 1-3C perfluoroalkyl or 1-3C alkyl substd. by CF3, NO2, ORd, COORd, CON(Rd)2, CN, N(Rd)2 or cyclopropyl; each Rd is H or 1-4C alkyl. Included are cpds. obtd. from (I) by mono-, di- or tri-acylation with R8COX' or by mono-, di- or tri-alkylation with R12X, and their pharmaceutically acceptable salts. X and X' = conventional leaving gp.; R8 = H, 1-12C alkyl (opt. contg. a double or triple bond and opt. substd. by CN, ORe, COORe, N(Rf)2 or CON(Rf)2); N(Rg)2; pyridyl, pyridyl(1-12C)alkyl; phenyl or phenyl(1-4C)alkyl opt. ring-substd. by 0-3 of halo, NH2, OH, CN, NO2 or 1-4C alkyl or alkoxy; Re = H, 1-4C alkyl, phenyl or phenyl(1-4C)alkyl (opt. ring-substd. as above); Rf = Rh, CORh or COORh in N(Rf)2 or Rh is CON(Rf)2; Rh is as Re or 2 together complete a satd. 4-7 membered ring; Rg are as Rh; R12 = 1-4C alkyl (opt. contg. a double or triple bond in which case a CH2 must be present between the multiple bond and the gp. to give R12 is attached); phenyl(1-4C)alkyl (opt. ring-substd. as above) or (CH2)mCOORa; Ra = H or 1-4C alkyl; m = 1-6.
Patent AU-1584099-A (AU)
Title: Method and apparatus for monitoring a patient
Inventor: VASKO ROBERT S
IPC: H04M11/00
Filed: 1998-11-12
Abstract: A remotely programmable and accessible medical device system (10) including an interface unit (14) and a medical device (12) connected to a patient (18) is disclosed. Through a transceiver, such as a telephone (48) or computer (50), a person may obtain status reports from a remotely located medical device in audible, electronic or paper form. In addition, the person may change a protocol associated with the medical device or be alerted to a remote location of an alarm associated with the medical device.
Patent AU-1604992-A (AU)
Title: Essentially pure human parathyroid hormone
IPC: C07K14/435
Filed: 1992-05-06
Abstract: Human parathyroid hormone is provided in an ultrapure form characterized by the absence of protein contaminants detectable by capillary electrophoresis analysis. A method for obtaining such ultrapure human parathyroid hormone is also described.
Patent AU-1710801-A (AU)
Title: Direct dyeing composition for keratinic fibres containing a thickening polymer with an ether plastic skeleton
Inventor: ALLARD DELPHINE
IPC: A61K8/40
Filed: 2000-11-10
Abstract: The invention relates to a direct dyeing composition for keratinic fibers, especially human keratinic fibers such as hair, containing at least one direct dye and a thickening polymer with an ether plastic skeleton, in a medium which is suitable for dyeing. The invention also relates to dyeing methods and devices for using the invention composition.
Patent AU-1790901-A (AU)
Title: Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1- piperazinepentanamides as HIV protease inhibitors
Inventor: TATA JAMES R
IPC: C07D491/048
Filed: 2000-11-21
Abstract: gamma-Hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamide compounds are inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. These compounds are effective against HIV viral mutants which are resistant to HIV protease inhibitors currently used for treating AIDS and HIV infection.
Patent AU-1848297-A (AU)
Title: Human dnase resistant to actin inhibition
Inventor: BAKER KEVIN P
IPC: C12N5/10
Filed: 1997-02-03
Abstract: This invention relates to a novel human deoxyribonuclease, referred to as LS-DNase, that is relatively resistant to inhibition by actin, as compared to human DNase I. The invention provides nucleic acid sequences encoding LS-DNase, thereby enabling the production of LS-DNase by recombinant DNA methods in quantities sufficient for clinical use. The invention also relates to pharmaceutical compositions and therapeutic uses of LS-DNase.
Patent AU-1935788-A (AU)
Title: A process for producing an administration and/or dosage form for medically active ingredients of drugs
Inventor: ANHAEUSER DIETER
IPC: A61K9/70
Filed: 1988-06-16
Abstract: The invention relates to a process for producing an administration and/or dosage form for medicament active substances using a printing process, in which the printing process used is a pad printing process.
Patent AU-2236497-A (AU)
Title: Catalyst for the selective oxidation of sulfur compounds to elemental sulfur, method for the preparation of such catalyst, and method for the selective oxidation of sulfur compounds to elemental sulfur
Inventor: GEUS JOHN WILHELM
IPC: B01J23/76
Filed: 1997-03-04
Abstract: The invention provides a catalyst, a method for making the catalyst and a method for using the catalyst to promote the selective oxidation of hydrogen sulfide into elemental sulfur. The catalyst may be prepared by contacting a catalyst support, such as silica, with a mixed oxide having atomically mixed iron ions and zinc ions, to produce a support material impregnated with a mixed oxide having atomically mixed iron ions and zinc ions in an oxidic lattice. This impregnated catalyst support is then dried and calcined, preferably with chloride ions present, to produce a catalyst of an iron and zinc oxide mixture supported on silica. It has been found that when chloride is added to the impregnated catalyst support prior to calcination and drying, the sintering of the iron and zinc can be controlled more easily and the formation of iron and zinc oxide is promoted. It has also been found that the catalyst of the invention exhibits improved selectivity characteristics when compared to a catalyst prepared without the chloride.
Patent AU-2737000-A (AU)
Title: Flexible heart valve
Inventor: CARPENTIER ALAIN F
IPC: A61F2/24
Filed: 2000-01-26
Abstract: A prosthetic heart valve (40) for implant at an aortic annulus, comprising: 
an elongate rod-like flexible stent (46, 250, 280, 290, 300, 310, 320) having alternating inflow cusps (60) and outflow commissures (62) made of an elastic material; 
a plurality of flexible leaflets (42) attached to the stent so as to form a one-way valve within the stent; and 
a suture-permeable connecting band (48) attached to the stent providing an interface between the valve and surrounding host tissue, wherein the connecting band shape mimics the alternating stent cusps and commissures and provides a flexible interface for suturing that conforms to a natural aortic root, and 
wherein the flexible stent is relatively more rigid than the leaflets and connecting band and acts to limit total flexibility of the valve, and wherein the stent is flexible to permit the cusps to move radially relative to each other about the commissures, and wherein the connecting band defines axial gaps (142) opening in the inflow direction between the cusps of the stent to minimize interference with pivoting movement of the stent cusps.
Patent AU-2866689-A (AU)
Title: Methods and articles for treating periodontal disease
Inventor: SCANTLEBURY TODD V
IPC: A61C8/00
Filed: 1989-01-20
Abstract: An article for treatment of periodontal disease is disclosed. In use, the gingival tissue is separated from a tooth surface in an area where periodontal disease is present. A biocompatible, porous material (22) capable of supporting ingrowth of gingival connective tissue and preventing apical migration of gingival epithelium is placed in a laminar relationship to a portion of the perimeter of the tooth surface. The gingival tissue is repositioned around the tooth and in contact with the porous material, with the porous material positioned between the gingival tissue and the tooth. One preferred article comprises a first portion (22) which is capable of supporting ingrowth of gingival connective tissue and preventing apical migration of gingival epithelium and a second portion (24) which is impermeable to oral tissues.
Patent AU-2883202-A (AU)
Title: System and method for supplying auxiliary power to a large diesel engine
Inventor: BIESS LAWRENCE J
IPC: F02N19/02
Filed: 2001-11-08
Abstract: A system and method for providing auxiliary power to a large diesel engine allowing shutdown of such large engine in all weather conditions. An auxiliary power unit made up of a secondary engine (45) coupled to an electrical generator (48) is provided. An automatic control system shuts down the primary engine (10) after a period of idling and the auxiliary power unit provides electrical power for heating and air conditioning. In cold weather, the auxiliary power unit maintains the primary engine coolant and lube-oil warm to facilitate engine restart. The coolant system (55) is kept warm using a heat changer (57) and electrical heaters. The lube-oil system is kept warm using a recirculating pump and electrical heaters. In warm weather, the auxiliary power unit provides electrical power for air conditioning and other hotel loads. The auxiliary power unit isolates the primary engine batteries during operation and provides electrical power for hotel and non-vital loads.
Patent AU-2884999-A (AU)
Title: Poly zinc finger proteins with improved linkers
Inventor: KIM JINSOO
IPC: A61K48/00
Filed: 1999-03-01
Abstract: Polynucleotides encoding chimeric proteins, and methods for their production and use are disclosed. The chimeric proteins comprise a flexible linker between two zinc finger DNA-binding domains, wherein the linker contains eight or more amino acids between the second conserved histidine residue of the carboxy-terminal zinc finger of the first domain and the first conserved cysteine residue of the amino-terminal zinc finger of the second domain.
Patent AU-2935501-A (AU)
Title: Steerable modular drilling assembly
Inventor: KRUEGER VOLKER
IPC: E21B47/12
Filed: 2001-01-11
Abstract: The present invention provides a modular drilling assembly having a module (520) for contactless power and data transfer over a nonconductive gap (113) between rotating (110) and non-rotating (120) members of a steering module. The downhole tool is a modular drilling assembly wherein a drive shaft (110) is rotated by a downhole motor to rotate a drill bit attached to the bottom end of the drive shaft (110). A substantially non-rotating sleeve around the drive shaft includes at least one electrically-operated device. The drilling assembly is modular in that it includes at least one steering module (510) at the bottom end of the drilling assembly that has at least one steering device module that provides power to the force application member. A number of additional modules can be provided to make up the entire drilling assembly, said modules being interchangeable.
Patent AU-2945695-A (AU)
Title: New hiv protease inhibitors
Inventor: HUNGATE RANDALL W
IPC: A61K31/27
Filed: 1995-06-19
Abstract: Oligopeptide analogs containing sulfonamide, urea or carbamate linkages in the backbone are described. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Patent AU-3137784-A (AU)
Title: Semiconductor device using fet:s
Inventor: PELGROM MARCELLINUS JOHANNES M
IPC: H01L29/78
Filed: 1984-08-01
Abstract: The invention relates to an integrated MOS circuit comprising a MOS transistor which is connected as a resistor and which, when current is passed, generates a voltage which is supplied to the sourceigate of a second field effect device. In order to obtain a suitable current adjustment, the two channel widths are chosen so that due to narrow channel effects a difference (though small) in threshold voltage is obtained. The invention is of particular interest for CCD input circuits for generating a small offset voltage required tor supplying FAT-zero.
Patent AU-3433699-A (AU)
Title: Therapeutic agent for ngf
Inventor: ROBERTSON ALAN GEORGE SIMPSON
IPC: C07K14/71
Filed: 1999-04-09
Abstract: This invention relates to the use of a domain of Trk as a therapeutic agent and for screening purposes and rational design of NGF mimetics.
Patent AU-3488184-A (AU)
Title: Oriented strand lay-up
Inventor: CHURCHLAND MARK T
IPC: B27M3/00
Filed: 1984-10-31
Abstract: A process and apparatus for continuously forming a product having elongate members (10) at least about one foot long which are oriented, compressed and bonded. The process comprises depositing elongate members (10) on a moving carrier (39) with an orientation that is substantially parallel to the direction of movement of said carrier (39), said members (14) being deposited on said carrier (39) over a length of carrier (39) that is at least as long as about one-half times the length of the elongate members (10) and is at least as long as about 30 times the final thickness of the compressed, composite product. The apparatus comprises a first conveyor (30) along which elongate members (10) travel, said elongate members (10) being arranged transverse to the direction of travel of said first conveyor (30). This first conveyor (30) feeds a second conveyor (33) which is arranged to move transversely of said first conveyor (30) and to collect said elongate members (10). The second conveyor (33) then feeds a third conveyor (39) whereupon the final product is formed.
Patent AU-3512897-A (AU)
Title: Automatic chemistry analyzer
Inventor: WATTS RICHARD
IPC: G01N35/02
Filed: 1997-06-30
Abstract: An automatic chemistry analyzer is provided having a high throughput and a high reliability. The analyzer uses nephelometric and turbimetric analyzers to analyze a wide variety of parameters within liquid samples typically generated in, for example, a large medical testing laboratory. The machine employs a unique probe and stirring rod assembly mounted at a slight angle with one another using rack and pinion assemblies so that the lower end of the probe and the lower end of the stirring rod are in very close proximity to one another. This feature allows the machine to be used in unusually small reaction cuvettes. The analysis machine also includes an onboard control sample so that the machine can be programmed to periodically calibrate its analyzing equipment during the course of normal operation. The machine also includes a sample station carousel having retainer clips for retaining a sample container rack which is constructed to retain a bar-coded card containing information regarding reagents used in the machine. A bar code reader located proximate to the sample carousel reads the bar-coded reagent information into the controller.